Full Text View
Tabular View
No Study Results Posted
Related Studies
Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
This study is currently recruiting participants.
Study NCT00305799   Information provided by National Cancer Institute (NCI)
First Received: March 21, 2006   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurotoxicity
Additional conditions recognized in this trial
Neoplasms
Neurotoxicity Syndromes
More general conditions related to this trial
Disorders of Environmental Origin
Nervous System Diseases
Poisoning
Interventions listed in this trial
management of therapy complications
Additional drug interventions recognized in this trial
Oxaliplatin
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Case Comprehensive Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services